Page last updated: 2024-11-02

phenylbutazone and Myelodysplastic Syndromes

phenylbutazone has been researched along with Myelodysplastic Syndromes in 1 studies

Phenylbutazone: A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS.
phenylbutazone : A member of the class of pyrazolidines that is 1,2-diphenylpyrazolidine-3,5-dione carrying a butyl group at the 4-position.

Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohyashiki, K1
Ohyashiki, JH1
Raza, A1
Preisler, HD1
Sandberg, AA1

Other Studies

1 other study available for phenylbutazone and Myelodysplastic Syndromes

ArticleYear
Phenylbutazone-induced myelodysplastic syndrome with Philadelphia translocation.
    Cancer genetics and cytogenetics, 1987, Volume: 26, Issue:2

    Topics: Aged; Humans; Karyotyping; Male; Myelodysplastic Syndromes; Phenylbutazone; Philadelphia Chromosome;

1987